Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > USA. M. HIF-2α Inhibitor Tab.>



USA. M. HIF-2α Inhibitor Tab.>'s subsections
(*) USA Approval Date: 2023. 12.14
>Following a PD-1 or PD-L1 Inhibit>
Company
Generic Name
TM
TM Web-Site
USA Patent Numbers

USA. M. HIF-2α Inhibitor Tab.>'s products
This section has no products